Inovalon Announces Third Quarter 2015 Earnings Conference Call

BOWIE, Md., Oct. 21, 2015 /PRNewswire/ -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based data analytics and data-driven intervention platforms to the healthcare industry, today announced that it will hold its third quarter 2015 financial results conference call at 5:00 p.m. EST on Wednesday, November 4, 2015. Chairman and Chief Executive Officer, Dr. Keith Dunleavy and Chief Financial Officer, Thomas Kloster will review the company's financial performance for the period. The news release announcing the financial results will be issued post market on Wednesday, November 4, 2015.

Dial-in phone number (855) 783-2604
International dial-in phone number (631) 485-4882
Conference ID 59121387

The call will be available for replay on Inovalon's investor relations website (

About Inovalon

Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 769,000 physicians, 261,000 clinical facilities, and more than 123 million Americans providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. For more information, visit


Investor Relations
Kim E. Collins
Phone: 301-809-4000 x1473

To view the original version on PR Newswire, visit:

SOURCE Inovalon

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.